EXECUTIVE SUMMARY

i.    Critical Care Overview

ii.    European Markets for Blood Gas Monitoring Products

a.   Market Analysis

iii.   Methodology

 

Exhibit ES-1:    Europe, Blood Gas Monitoring Products, Market Forecast, 2008-2013

 

1. EUROPEAN HEALTHCARE MARKETS

1.1 The European Union

1.1.1 A Common Currency

1.1.2 Regulatory Policies

1.1.3 Reimbursement

1.1.4 Healthcare Spending

1.2 Selected European National Healthcare Profiles

1.2.1 France

1.2.1.1 Healthcare Organization and Reform

1.2.1.2 Hospital Services

1.2.1.3 Medical Device Reimbursement

1.2.2 Germany

1.2.2.1 Healthcare Organization and Reform

1.2.2.2 Hospital Services

1.2.2.3 Medical Device Reimbursement

1.2.3 Italy

1.2.3.1 Healthcare Organization and Reform

1.2.3.2 Hospital Services

1.2.3.3 Medical Device Reimbursement

1.2.4 Spain

1.2.4.1 Healthcare Organization and Reform

1.2.4.2 Hospital Services

1.2.4.3 Medical Device Reimbursement

1.2.5 United Kingdom

1.2.5.1 Healthcare Organization and Reform

1.2.5.2 Hospital Services

1.2.5.3 Medical Device Reimbursement

 

Exhibit 1-1:      European Union, Medical Devices Risk Classification System

Exhibit 1-2:      Europe, Population Statistics Comparison for the Years 2008 and 2018

Exhibit 1-3:      France, Selected National Healthcare Statistics

Exhibit 1-4:      Germany, Selected National Healthcare Statistics

Exhibit 1-5:      Italy, Selected National Healthcare Statistics

Exhibit 1-6:      Spain, Selected National Healthcare Statistics

Exhibit 1-7:      United Kingdom, Selected National Healthcare Statistics

 

2. OVERVIEW OF THE CRITICAL CARE ENVIRONMENT

2.1 Conditions Treated in the Critical Care Unit

2.2 Critical Care Unit Staffing

2.2.1 Intensivists

2.2.2 Nurses and Other Allied Healthcare Professionals

2.3 Critical Care Units, by Size and Type

2.4 Equipment and Products Used in the Critical Care Setting

2.4.1 Invasive and Noninvasive Equipment and Products

2.4.2 Transport Equipment and Products

2.5 Critical Access Hospital Designation

2.6 Issues Affecting Critical Care Delivery

2.6.1 Patient Demographics

2.6.2 Managed Care

2.6.3 Healthcare Personnel Shortages

2.6.4 Trends in Critical Care Product Purchasing

 

Exhibit 2-1:      2006, Number of Anesthetists/Intensivists in Selected European Countries 

Exhibit 2-2:      Selected Critical Care Nursing and Allied Healthcare Responsibilities

Exhibit 2-3:      2006, Number of Emergency Rooms and Beds in Selected European Countries

Exhibit 2-4:      2006, Total Equipped Positions, by Type of Intensive Care Unit and Facility in Selected European Countries

Exhibit 2-5:      2006, France, Total Equipped Positions, by Type of Intensive Care Unit and Facility

Exhibit 2-6:      2006, Germany, Total Equipped Positions, by Type of Intensive Care Unit and Facility

Exhibit 2-7:      2006, Italy, Total Equipped Positions, by Type of Intensive Care Unit and Facility

Exhibit 2-8:      2006, Spain, Total Equipped Positions, by Type of Intensive Care Unit and Facility

Exhibit 2-9:      2006, United Kingdom, Total Equipped Positions, by Type of Intensive Care Unit and Facility

 

3. EUROPEAN MARKETS FOR CRITICAL CARE BLOOD GAS MONITORING PRODUCTS

3.1 Overview of Blood Gases

3.1.1 Arterial Blood Gas Sampling

3.1.2 Arterial Blood Gas Monitoring Methods

3.2 Point of Care Blood Gas Analyzers

3.2.1 Market Forecast

3.2.2 Competitive Analysis

3.3 Laboratory-Based Blood Gas Analyzers

3.3.1 Market Forecast

3.3.2 Competitive Analysis

3.4 Arterial Blood Gas Sampling Devices

3.4.1 Market Forecast

3.4.2 Competitive Analysis

3.5 Pulse Oximeters

3.5.1 Market Forecast

3.5.2 Competitive Analysis

3.6 Capnography/End-Tidal Carbon Dioxide Monitoring

3.6.1 Market Forecast

3.6.2 Competitive Analysis

3.7 Combined Market Forecast, Blood Gas Monitoring Systems

 

Exhibit 3-1:      2009, Selected Point of Care Blood Gas Testing Products

Exhibit 3-2:      Europe, Point of Care Blood Gas Testing Products, Market Forecast, 2008-2013

Exhibit 3-3:      2008, Europe, Point of Care Blood Gas Testing Products Market, Share by Supplier

Exhibit 3-4:      2009, Selected Laboratory-Based Blood Gas Analyzers

Exhibit 3-5:      Europe, Laboratory-Based Blood Gas Analyzers, Market Forecast, 2008-2013

Exhibit 3-6:      2008, Europe, Laboratory-Based Blood Gas Analyzers Market, Share by Supplier

Exhibit 3-7:      2009, Selected Arterial Blood Gas Sampling Devices

Exhibit 3-8:      Europe, Arterial Blood Gas Sampling Devices, Market Forecast, 2008-2013

Exhibit 3-9:      2008, Europe, Arterial Blood Gas Sampling Devices Market, Share by Supplier

Exhibit 3-10:    2009, Selected Pulse Oximetry Products

Exhibit 3-11:    Europe, Pulse Oximetry Products, Market Forecast, 2008-2013

Exhibit 3-12:    2008, Europe, Pulse Oximetry Monitors Market, Share by Supplier

Exhibit 3-13:    Advantages and Disadvantages of Mainstream and Sidestream Capnography Sampling

Exhibit 3-14:    2009, Selected Capnography-Only Units

Exhibit 3-15:    2009, Selected Capnography/Oximetry Units

Exhibit 3-16:    Europe, Capnography/End-Tidal Carbon Dioxide Monitoring Products, Market Forecast, 2008-2013

Exhibit 3-17:    2008, Europe, Capnography/End-Tidal Carbon Dioxide Monitors Market, Share by Supplier

Exhibit 3-18:    Europe, Blood Gas Monitoring Products, Combined Market Forecast, 2008 to 2013

 

4. COMPANY PROFILES

4.1       Abbott Laboratories

4.2       Covidien LTD

4.3       Danaher Corporation

4.4       General Electric Company

4.5       Masimo Corporation

4.6       Roche Holding AG

4.7       Royal Philips Electronics NV

4.8       Siemens AG

4.9       Smiths Group PLC

4.10     Werfen Group S.A.

 

APPENDIX:     COMPANY LISTING